Pathkey.ai Ltd (PKY) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Pathkey.ai Ltd (PKY) has a cash flow conversion efficiency ratio of 1.994x as of December 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-619.98K ≈ $-438.67K USD) by net assets (AU$-310.99K ≈ $-220.05K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Pathkey.ai Ltd net asset quality index to measure how much of total assets are equity-financed.
Pathkey.ai Ltd - Cash Flow Conversion Efficiency Trend (1996–2024)
This chart illustrates how Pathkey.ai Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check PKY cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Pathkey.ai Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Pathkey.ai Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Carbon Revolution Public Limited Ordinary Shares
NASDAQ:CREV
|
0.137x |
|
Pyxis Tankers Inc
NASDAQ:PXSAW
|
0.033x |
|
Lixte Biotechnology Holdings Inc
NASDAQ:LIXTW
|
-0.189x |
|
Ordinary Fully Paid Deferred Settlement
AU:EDEDA
|
-1.051x |
|
Ordinary Fully Paid Deferred Settlement
AU:ADDDB
|
N/A |
|
Shineco Inc
NASDAQ:SISI
|
-0.017x |
|
Lucy Scientific Discovery Inc.
NASDAQ:LSDIF
|
-9.112x |
|
NLS Pharmaceutics AG
NASDAQ:NLSPW
|
-0.719x |
Annual Cash Flow Conversion Efficiency for Pathkey.ai Ltd (1996–2024)
The table below shows the annual cash flow conversion efficiency of Pathkey.ai Ltd from 1996 to 2024. For the full company profile with market capitalisation and key ratios, see PKY company net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-06-30 | AU$-90.16K ≈ $-63.79K |
AU$-2.06 Million ≈ $-1.46 Million |
22.811x | +50.75% |
| 2023-06-30 | AU$-90.16K ≈ $-63.79K |
AU$-1.36 Million ≈ $-965.34K |
15.132x | -97.09% |
| 2022-06-30 | AU$-2.63K ≈ $-1.86K |
AU$-1.36 Million ≈ $-965.34K |
519.342x | +38287.97% |
| 2021-06-30 | AU$664.47K ≈ $470.15K |
AU$-903.65K ≈ $-639.39K |
-1.360x | -229.23% |
| 2020-06-30 | AU$2.19 Million ≈ $1.55 Million |
AU$-903.65K ≈ $-639.39K |
-0.413x | +96.02% |
| 2019-06-30 | AU$202.81K ≈ $143.50K |
AU$-2.10 Million ≈ $-1.49 Million |
-10.369x | -212.03% |
| 2018-06-30 | AU$-309.45K ≈ $-218.96K |
AU$-2.86 Million ≈ $-2.03 Million |
9.255x | +548.24% |
| 2017-06-30 | AU$1.39 Million ≈ $986.43K |
AU$-2.88 Million ≈ $-2.04 Million |
-2.065x | +73.03% |
| 2016-06-30 | AU$407.06K ≈ $288.02K |
AU$-3.12 Million ≈ $-2.20 Million |
-7.655x | -4256.49% |
| 2015-06-30 | AU$2.22 Million ≈ $1.57 Million |
AU$-389.85K ≈ $-275.85K |
-0.176x | -1328.94% |
| 2014-06-30 | AU$5.92 Million ≈ $4.19 Million |
AU$-72.76K ≈ $-51.48K |
-0.012x | +59.48% |
| 2013-06-30 | AU$8.31 Million ≈ $5.88 Million |
AU$-252.29K ≈ $-178.51K |
-0.030x | -110.59% |
| 2012-06-30 | AU$10.12 Million ≈ $7.16 Million |
AU$-145.87K ≈ $-103.21K |
-0.014x | +40.22% |
| 2011-06-30 | AU$14.17 Million ≈ $10.02 Million |
AU$-341.50K ≈ $-241.63K |
-0.024x | +88.08% |
| 2010-06-30 | AU$1.69 Million ≈ $1.19 Million |
AU$-341.50K ≈ $-241.63K |
-0.202x | -124.98% |
| 2009-06-30 | AU$-4.04 Million ≈ $-2.86 Million |
AU$-3.27 Million ≈ $-2.31 Million |
0.810x | +1817.81% |
| 2008-06-30 | AU$69.38 Million ≈ $49.09 Million |
AU$-3.27 Million ≈ $-2.31 Million |
-0.047x | -11.32% |
| 2007-06-30 | AU$59.61 Million ≈ $42.18 Million |
AU$-2.52 Million ≈ $-1.79 Million |
-0.042x | +9.51% |
| 2006-06-30 | AU$33.25 Million ≈ $23.53 Million |
AU$-1.56 Million ≈ $-1.10 Million |
-0.047x | +52.98% |
| 2005-06-30 | AU$13.41 Million ≈ $9.49 Million |
AU$-1.33 Million ≈ $-944.26K |
-0.100x | -367.82% |
| 2004-06-30 | AU$16.09 Million ≈ $11.38 Million |
AU$-342.24K ≈ $-242.16K |
-0.021x | +41.20% |
| 2003-06-30 | AU$10.47 Million ≈ $7.41 Million |
AU$-378.80K ≈ $-268.03K |
-0.036x | -20.83% |
| 2002-06-30 | AU$9.85 Million ≈ $6.97 Million |
AU$-294.88K ≈ $-208.64K |
-0.030x | +44.96% |
| 2001-06-30 | AU$8.89 Million ≈ $6.29 Million |
AU$-483.84K ≈ $-342.34K |
-0.054x | +36.89% |
| 2000-06-30 | AU$9.41 Million ≈ $6.66 Million |
AU$-811.63K ≈ $-574.28K |
-0.086x | -99.74% |
| 1999-06-30 | AU$6.41 Million ≈ $4.53 Million |
AU$-276.48K ≈ $-195.63K |
-0.043x | +7.67% |
| 1998-06-30 | AU$6.42 Million ≈ $4.54 Million |
AU$-299.97K ≈ $-212.25K |
-0.047x | +41.37% |
| 1997-06-30 | AU$6.21 Million ≈ $4.39 Million |
AU$-495.03K ≈ $-350.27K |
-0.080x | +53.83% |
| 1996-06-30 | AU$6.15 Million ≈ $4.35 Million |
AU$-1.06 Million ≈ $-751.81K |
-0.173x | -- |
About Pathkey.ai Ltd
Pathkey.AI Ltd, a digital health company, involves artificial intelligence (AI) to improve clinical trials and predicting outcomes for patients in Australia. The company offers TrialKey, an AI-driven clinical trial optimization and success prediction platform, that simulate and optimize trial designs. It also provides TrialGen, an AI-powered tool streamlines clinical trial design process. The com… Read more